Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions
Mutations in human pluripotent stem cells (PSC) and whether any form during culture prior to use in a human clinical context are a concern. Here, the authors use hPSCs derived to cGMP standards and show they have low mutation rates after culture, noting this decreases on culturing in low (5%) oxygen...
Guardado en:
Autores principales: | Oliver Thompson, Ferdinand von Meyenn, Zoe Hewitt, John Alexander, Andrew Wood, Richard Weightman, Sian Gregory, Felix Krueger, Simon Andrews, Ivana Barbaric, Paul J. Gokhale, Harry D. Moore, Wolf Reik, Marta Milo, Serena Nik-Zainal, Kosuke Yusa, Peter W. Andrews |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f55e007701f4013b3a7b971436b8888 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Generation and trapping of a mesoderm biased state of human pluripotency
por: Dylan Stavish, et al.
Publicado: (2020) -
Histone modifications form a cell-type-specific chromosomal bar code that persists through the cell cycle
por: John A. Halsall, et al.
Publicado: (2021) -
Widespread reorganisation of pluripotent factor binding and gene regulatory interactions between human pluripotent states
por: Peter Chovanec, et al.
Publicado: (2021) -
Ageing affects DNA methylation drift and transcriptional cell-to-cell variability in mouse muscle stem cells
por: Irene Hernando-Herraez, et al.
Publicado: (2019) -
Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries
por: Swee Hoe Ong, et al.
Publicado: (2017)